Descriptor English: | Gabexate | ||||
Descriptor Spanish: |
Gabexato
| ||||
Descriptor Portuguese: | Gabexato | ||||
Descriptor French: | Gabexate | ||||
Entry term(s): |
Foy Gabexate Mesilate Gabexate Mesylate Gabexate Methanesulfonate Gabexate Monomethanesulfonate Gabexate Monomethanesulfonate, 14C Labeled Cpd Gabexate Monomethanesulfonate, 14C-Labeled Cpd Mesilate, Gabexate Mesylate, Gabexate Methanesulfonate, Gabexate Monomethanesulfonate, Gabexate |
||||
Tree number(s): |
D02.078.370.380 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D016670 | ||||
Scope note: | A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Anticoagulants Serine Proteinase Inhibitors |
||||
Registry Number: | 4V7M9137X9 | ||||
CAS Type 1 Name: | Benzoic acid, 4-((6-((aminoiminomethyl)amino)-1-oxohexyl)oxy)-, ethyl ester | ||||
Previous Indexing: |
Anticoagulants (1966-1991) Guanidines (1966-1991) Protease Inhibitors (1979-1989) Serine Proteinase Inhibitors (1990-1991) |
||||
Public MeSH Note: | 92; GABEXATE was indexed under GUANIDINES 1976-91 |
||||
Online Note: | use GABEXATE (NM) to search GABEXATE 1979-91 |
||||
History Note: | 92; was GABEXATE (NM) 1976-91 |
||||
DeCS ID: | 30093 | ||||
Unique ID: | D016670 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1992/01/01 | ||||
Date of Entry: | 1991/01/25 | ||||
Revision Date: | 2013/07/08 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals
|
Gabexate
- Preferred
Gabexate Monomethanesulfonate, 14C-Labeled Cpd
- Narrower
Gabexate Monomethanesulfonate
- Narrower
Foy
- Narrower
Gabexate Methanesulfonate
- Narrower
Concept UI |
M0025401 |
Scope note | A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin. |
Preferred term | Gabexate |
Concept UI |
M0329388 |
Preferred term | Gabexate Monomethanesulfonate, 14C-Labeled Cpd |
Entry term(s) |
Gabexate Monomethanesulfonate, 14C Labeled Cpd |
Concept UI |
M0329389 |
Preferred term | Gabexate Monomethanesulfonate |
Entry term(s) |
Monomethanesulfonate, Gabexate |
Concept UI |
M0025402 |
Preferred term | Foy |
Concept UI |
M0329387 |
Preferred term | Gabexate Methanesulfonate |
Entry term(s) |
Gabexate Mesilate Gabexate Mesylate Mesilate, Gabexate Mesylate, Gabexate Methanesulfonate, Gabexate |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey